Treatment and disease progression in a birth cohort of vertically HIV-1 infected children in Ukraine

BMC Pediatrics

Volumn 10, Issue , 2010, Pages

  Mahdavi, Saboura ^a   Malyuta, Ruslan ^b   Semenenko, Igor ^b   Pilipenko, Tatyana ^b   Thorne, Claire ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Perinatal Prevention of AIDS Initiative   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; LAMIVUDINE; LOPINAVIR; TRIMETHOPRIM; VIRUS RNA; ZIDOVUDINE; ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BACTERIAL INFECTION; BRAIN DISEASE; CANDIDIASIS; CHILD; CHILDHOOD MORTALITY; DISEASE COURSE; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE DEFICIENCY; INFECTION PREVENTION; LUNG MYCOSIS; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PREGNANT WOMAN; PROSPECTIVE STUDY; SURVIVAL; SURVIVAL RATE; TREATMENT DURATION; TREATMENT RESPONSE; TUBERCULOSIS; UKRAINE; VERTICAL TRANSMISSION; WASTING SYNDROME; WEIGHT REDUCTION; DISEASE TRANSMISSION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PREVALENCE; PROGNOSIS;

ANTI-RETROVIRAL AGENTS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RNA, VIRAL; SURVIVAL RATE; UKRAINE;

EID: 78649927700     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-10-85     Document Type: Article

References (40)

1. Burruano L, Kruglov Y. HIV/AIDS epidemic in Eastern Europe: recent developments in the Russian Federation and Ukraine among women. Gend Med 2009, 6:277-289. 10.1016/j.genm.2009.04.009, 19467524.
2. Malyuta R, Newell ML, Ostergren M, Thorne C, Zhilka N. Prevention of mother-to-child transmission of HIV infection: Ukraine experience to date. Eur J Public Health 2006, 16:123-127. 10.1093/eurpub/cki150, 16476684.
3. WHO, UNAIDS, UNICEF Epidemiological Fact Sheet on HIV and AIDS Core data on epidemiology and response. 2009, 1-18. Ukraine, WHO, UNAIDS, UNICEF.
4. Thorne C, Semenenko I, Pilipenko T, Malyuta R. Progress in prevention of mother-to-child transmission of HIV infection in Ukraine: results from a birth cohort study. BMC Infect Dis 2009, 9:40. 10.1186/1471-2334-9-40, 2674441, 19351387.
5. UNAIDS. Country situation: Ukraine 2009, 1-4. UNAIDS: Geneva, UNAIDS. Country situation: Ukraine.
6. Ministry of Health of Ukraine Ukraine National Report on Monitoring Progress Towards the UNGASS Declaration of Commitment on HIV/AIDS; Reporting period January 2006 - December 2007. 2008, Kiev, Ukraine, Ministry of Health of Ukraine.
7. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, et al. Early Antiretroviral Therapy and Mortality among HIV-Infected Infants. N Engl J Med 2008, 359:2233-2244. 10.1056/NEJMoa0800971, 2950021, 19020325.
8. European Collaborative Study CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation?. JInfect Dis 2006, 193:954-962. European Collaborative Study.
9. Goetghebuer T, Haelterman E, Le Chenadec J, Dollfus C, Gibb D, Judd A, et al. Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. AIDS 2009, 23:597-604. 10.1097/QAD.0b013e328326ca37, 19194272.
10. Resino S, Resino R, Micheloud D, Gurbindo GD, Leon JA, Ramos JT, et al. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up. Clin Infect Dis 2006, 42:862-869. 10.1086/500412, 16477566.
11. Blanche S, Newell M-L, Mayaux M-J, Dunn DT, Teglas JP, Rouzioux C, et al. Morbidity and mortality in European children vertically infected by HIV-1: The French Pediatric HIV Infection Study Group and European Collaborative Study. J Acquir Immune Defic Syndr Hum Retrovirol 2009, 14:442-450.
12. Doerholt K, Duong T, Tookey P, Butler K, Lyall H, Sharland M, et al. Outcomes for Human Immunodeficiency Virus-1-infected infants in the United Kingdom and Republic of Ireland in the era of effective antiretroviral therapy. Pediatr Infect Dis J 2006, 25:420-426. 10.1097/01.inf.0000214994.44346.d3, 16645506.
13. Walker AS, Doerholt K, Sharland M, Gibb DM, . Collaborative HIV Paediatric Study (CHIPS) Steering Committee Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study. AIDS 2004, 18:1915-1924. 10.1097/00002030-200409240-00007, 15353977, Collaborative HIV Paediatric Study (CHIPS) Steering Committee.
14. European Collaborative Study The mother-to-child HIV transmission epidemic in Europe: evolving in the East and established in the West. AIDS 2006, 20:1419-1427. 10.1097/01.aids.0000233576.33973.b3, 16791017, European Collaborative Study.
15. UNAIDS, UNICEF, World Health Organisation Unite For Children, Unite Against AIDS. Children and AIDS, Second Stocktaking Report, Action and progress. 2009, 1-48. UNAIDS, Geneva, UNAIDS, UNICEF, World Health Organisation.
16. The Collaboration of Observational HIV Epidemiological Research Europe Study Group Response to combination antiretroviral therapy: variation by age. AIDS 2008, 22:1463-1473. 10.1097/QAD.0b013e3282f88d02, 18614870, The Collaboration of Observational HIV Epidemiological Research Europe Study Group.
17. The European Collaborative Study Fluctuations in symptoms in Human Immunodeficiency Virus-infected children: the first 10 years of life. Pediatrics 2001, 108:116-122. 10.1542/peds.108.1.116, 11433063, The European Collaborative Study.
18. Centers for Disease Control and Prevention 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. Morb Mortal Wkly Rep 1994, 1-20. RR-12, Centers for Disease Control and Prevention.
19. Scherpbier HJ, Bekker V, van Leth F, Jurriaans S, Lange JMA, Kuijpers TW. Long-term Experience With Combination Antiretroviral Therapy That Contains Nelfinavir for up to 7 Years in a Pediatric Cohort. Pediatrics 2006, 117:e528-e536. 10.1542/peds.2005-1272, 16481448.
20. Chiappini E, Galli L, Tovo PA, Gabiano C, Lisi C, Bernardi S, et al. Five-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy. BMC Infect Dis 2009, 9:140. 10.1186/1471-2334-9-140, 2753343, 19709432.
21. World Health Organization Antiretroviral therapy for HIV infection in infants and children: towards universal access (2010 revision). WHO, Geneva, World Health Organization., http://www.who.int/hiv/pub/paediatric/infants2010/en/index.html
22. Foster C, Judd A, Tookey P, Tudor-Williams G, Dunn D, Shingadia D, et al. Collaborative HIV Paediatric Study (CHIPS) Young people in the United Kingdom and Ireland with perinatally acquired HIV: The pediatric legacy for adult services. AIDS Patient Care and STDs 2009, 23:159-166. 10.1089/apc.2008.0153, 19866533, Collaborative HIV Paediatric Study (CHIPS).
23. World Health Organization, UNAIDS Provisional WHO/UNAIDS recommendation on the use of cotrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa. Afr Health Sci 2001, 1:30-31. 2704444, 12833907, World Health Organization, UNAIDS.
24. World Health Organization, UNAIDS, UNICEF Joint WHO/UNAIDS/UNICEF statement on use of cotrimoxazole as prophylaxis in HIV-exposed and HIV-infected children. 2004, Geneva, WHO, World Health Organization, UNAIDS, UNICEF., http://www.who.int/3by5/mediacentre/en/Cotrimstatement.pdf
25. Centers for Disease Control and Prevention 1995 Revised Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to Immunodefeciency Virus. MMWR Recomm Rep 1995, 44(RR-4):1-11. Centers for Disease Control and Prevention.
26. Chintu C, Bhat GJ, Walker AS, Mulenga V, Sinyinza F, Lishimpi K, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet 2004, 364:1865-1871. 10.1016/S0140-6736(04)17442-4, 15555666.
27. Rouet F, Sakarovitch C, Msellati P, Elenga N, Montcho C, Viho I, et al. Pediatric viral Human Immunodeficiency Virus Type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children. Pediatrics 2003, 112:e289. 10.1542/peds.112.4.e289, 14523214.
28. Rich KC, Fowler MG, Mofenson LM, Abboud R, Pitt J, Diaz C, et al. Maternal and infant factors predicting disease progression in Human Immunodeficiency Virus Type 1-infected infants. Pediatrics 2000, 105:e8. 10.1542/peds.105.1.e8, 10617745.
29. Chearskul S, Chotpitayasunondh T, Simonds RJ, Wanprapar N, Waranawat N, Punpanich W, et al. Survival, disease manifestations, and early predictors of disease progression among children with perinatal Human Immunodeficiency Virus infection in Thailand. Pediatrics 2002, 110:e25. 10.1542/peds.110.2.e25, 12165624.
30. Rekha B, Swaminathan S. Childhood tuberculosis - global epidemiology and the impact of HIV. Paediatr Respir Rev 2007, 8:99-106. 10.1016/j.prrv.2007.04.010, 17574153.
31. WHO European Health for All Database (HFA-DB) WHO website (Regional Office for Europe). 2009, WHO European Health for All Database (HFA-DB)., http://data.euro.who.int/hfadb/
32. Carter M. HIV/AIDS epidemic in Eastern Europe a "public health disaster". aidsmap news 2009, http://blog.aidsmap.com/page/1436884/
33. Alcon K. HIV a major risk factor for MDR TB in Ukraine. aidsmap news 2007, http://www.aidsmap.com/page/1428826/
34. UNAIDS Comprehensive External Evaluation of the National AIDS Response in Ukraine. Consolidated Report 2009, Kiev, Ukraine: UNAIDS, UNAIDS.
35. Scott GB, Hutto C, Makuch RW, Mastrucci MT, O'Connor T, Mitchell CD, et al. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med 1989, 321:1791-6. 10.1056/NEJM198912283212604, 2594038.
36. Khaldeeva N, Hillis SD, Vinogradova E, Voronin E, Rakhmanova A, Yakovlev A, et al. HIV-1 seroprevalence rates in women and relinquishment of infants to te state in St Petersburg, Russia. The Lancet 2002, 362.
37. Transatlantic Partners Against AIDS Abandoned Children born to HIV Positive Women: Analysis of the Situation in Russia. 2004, Moscow: Transatlantic Partners Against AIDS, Transatlantic Partners Against AIDS.
38. European Collaborative Study Social care of children born to HIV-infected mothers in Europe. AIDS care 1998, 10:7-16. 10.1080/713612346, 9536198, European Collaborative Study.
39. Thorne C, Newell ML. Prevention of HIV Infection in Infants. Documenting and Learning from the Ukraine experience 2005, Kiev: UNICEF.
40. Bailey H, Semenenko I, Pilipenko T, Malyuta R, Thorne C, . Ukraine European Collaborative Study Group Factors associated with abandonment of infants born to HIV positive women: results from a Ukrainian birth cohort. AIDS Care 2010, epub 06/09/20, Ukraine European Collaborative Study Group.